
The Ashton Manual is a guide to coming off benzodiazepines slowly. Its full title is “Benzodiazepines: How They Work and How to Withdraw,” and Professor C. Heather Ashton wrote it in 1999 and revised it in 2002. It is free to read at benzo.org.uk.
The method fits in one sentence. Most people are moved gradually to diazepam (Valium), and then the dose comes down in small steps over many months, at a pace the patient controls. It is the reference that Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, builds his tapers on.
The Manual was written for people who took a medication as prescribed and then found that they could not stop it. That is physical dependence, the body’s adaptation to a drug taken every day. Physical dependence is not addiction. In fact, Chapter I of the Manual describes dependence on ordinary prescribed doses as a type of its own, distinct from recreational use.
Professor Ashton was a physician. She studied at the University of Oxford, qualified in medicine in 1954, and became Professor of Clinical Psychopharmacology, the science of how medications act on the brain, at Newcastle University.
From 1982 to 1994, she ran a benzodiazepine withdrawal clinic, and the Manual is what she learned in those twelve years. She wrote it at the request of readers in the United States, added a supplement in 2011, and died in 2019. The Manual has been translated into many languages.
All benzodiazepines work by strengthening gamma-aminobutyric acid (GABA), the brain’s own calming chemical. Over months of daily use, the nervous system adjusts to that extra calming. When the medication is taken away suddenly, the adjusted nervous system is left overexcited.
The Manual warns, in Chapter II, that abrupt or over-rapid withdrawal, especially from a high dose, can cause convulsions, psychotic reactions, and acute anxiety states. The 2020 boxed warning update from the United States Food and Drug Administration (FDA) put a similar warning on every benzodiazepine label: stopping abruptly or reducing the dose rapidly can set off withdrawal reactions, including seizures, that can be life-threatening. Anyone who has a seizure, or any other medical emergency, needs emergency services called right away.
Two other problems follow a fast stop. Rebound is the return of the original anxiety or insomnia, stronger than before. Kindling is the name for a pattern in which repeated rounds of stopping suddenly and starting again seem to make each withdrawal harder than the last.
Unfortunately, many people who search for a benzodiazepine detox expect something quick. What the Manual teaches is the opposite, a gradual, medically supervised taper that takes months, and sometimes longer.
Fortunately, those dangers belong to stopping fast. Chapter III states that seizures are extremely rare with a slowly eliminated benzodiazepine such as diazepam, or with slow tapering.
Short-acting benzodiazepines, such as alprazolam (Xanax) and lorazepam (Ativan), are eliminated fairly quickly. Blood levels rise and fall between doses, and many patients feel withdrawal symptoms before the next tablet is due, known as interdose withdrawal. A smooth reduction is hard to build on a drug like that.
Diazepam solves two problems at once. It is one of the most slowly eliminated benzodiazepines, with a half-life of up to 200 hours when its active breakdown products are counted, so the level in the body falls gently from one day to the next. It also comes in 2 mg tablets that are scored to break cleanly in half, which makes very small reductions possible. For those reasons, Chapter II calls diazepam the only benzodiazepine that is ideal for the purpose.
One point is often misunderstood. Diazepam is not slow to work. It is absorbed quickly, and what is slow is the way it leaves the body, which is the property a taper needs.
The switch itself, known as a crossover taper, is not made overnight. The Manual describes it as gradual and stepwise, with one dose replaced at a time, and a separate article explains why the Manual recommends switching to diazepam before a taper.
Not everyone needs the switch. A person who already takes diazepam tapers the diazepam, and the Manual’s example schedules include a direct taper of chlordiazepoxide (Librium), which is also slowly eliminated. Yet, the Manual adds that limited tablet strengths can make a move to diazepam necessary even from a fairly long-acting drug.
Before a switch, the prescriber has to work out how much diazepam matches the current dose. Table 1, in Chapter I, lists each benzodiazepine beside its rough equivalent in diazepam.
The numbers surprise people. By that table, alprazolam and clonazepam (Klonopin) are about twenty times as strong as diazepam, milligram for milligram, and lorazepam is about ten times as strong. So, a prescription that looks small on the bottle can be a large dose in diazepam terms.
However, the figures are approximate. The Manual says that the equivalents differ between individuals, and that they do not agree with the figures some other authors use. A conversion from the Manual’s dose conversion chart is a starting estimate, and the prescriber adjusts it to how the patient actually feels.
A pilot does not land an airplane by pointing it at the ground. The descent is long and shallow, and it flattens out even more as the runway gets close. A benzodiazepine taper should have the same shape.
In Chapter II, the Manual suggests aiming for reductions of up to one tenth of the dose at each step, with a week or two between steps. As the dose comes down, the steps get smaller.
Yet, “up to one tenth” is a ceiling, and the schedules are examples that the Manual says may need to be adapted. The Manual tells the reader, in its own words, to be in control of the schedule and to proceed at the pace that is comfortable.
This is why fixed timelines fail. A taper that has to end by a set date ignores how the patient’s nervous system is handling each step. A taper that falls apart has usually been pushed too fast.
Even on a slow taper, symptoms come and go. Chapter III describes them as waxing and waning in waves, with windows of feeling normal that appear after some weeks. Anxiety, poor sleep, muscle tension, and sensitivity to light and sound are among the common ones.
So, when a step proves hard, the Manual’s advice is to stay at that dose for a few weeks, called a hold, and let the body catch up. Professor Ashton advised patients to try not to go back up, while Dr. Leeds considers a small increase in dose, called an updose, legitimate when a reduction turns out to have been too large.
The Manual’s position, in Chapter III, is that additional drugs are seldom needed with a very slow taper. In Chapter II, it calls a counselor or therapist often valuable for teaching relaxation techniques, but it does not make counseling a condition of a taper.
Fortunately, the larger picture is reassuring. The Manual states that withdrawal symptoms can be minimized and largely avoided by slow tapering fitted to the individual. A minority of people have symptoms that linger after the last dose, known as protracted withdrawal, and the Manual reports that these decline steadily with time.
The Manual’s steps shrink as the dose falls. The Maudsley Deprescribing Guidelines explain why that works and carry it further, in a pattern called hyperbolic tapering. Each reduction is sized as a proportion of the current dose, so every step is smaller than the one before.
The reason is that the last few milligrams do more work in the brain than the first few did. A reduction that was easy at a high dose can be far too large near the end.
Reductions can be made stepwise, as a cut followed by a hold, or by microtapering, which uses very small reductions every day or every few days, usually with a liquid. Microtapering exists for people who cannot tolerate stepwise cuts.
The end of the taper is one place where Dr. Leeds departs from the Manual. Professor Ashton taught from 2 mg tablets, and her advice was to stop once the dose was down to a fraction of one tablet. That remains an option for a patient who is doing well and chooses it.
His default, with the manufactured diazepam oral solution, is to keep reducing in steps sized to the remaining dose, down to a very small stopping point agreed in advance. The last step should feel like just another step, a question taken up in how low a taper should go before the last dose.
The Manual was written for patients to read. However, it expects a doctor to be involved, and it says the doctor’s agreement and cooperation are necessary, because the doctor writes the prescription. What it warns against is stopping abruptly or reducing too fast, and a slow taper planned with the prescriber is what it teaches.
There is no fixed length. In Chapter II, the Manual’s rough example of a diazepam taper could last 30 to 60 weeks, and it adds that some people might go even slower. The drug, the dose, the years of use, and above all the patient’s response decide the timeline, and a separate article looks at how long an Ashton Manual taper takes.
Yes. Table 1 lists z-drugs, the sleeping pills such as zolpidem (Ambien) and zopiclone, beside the benzodiazepines, and one example schedule tapers zopiclone by way of diazepam. They act on the same receptors, so the same principles apply: no sudden stop, small steps, and a pace the patient sets.
Dr. Leeds is one physician, and his practice’s primary service is medically supervised tapering of benzodiazepines and z-drugs for patients in Florida. It is a concierge practice that does not bill insurance, and every patient works with him directly.
The Ashton Manual is the foundation of each plan, and the Maudsley Deprescribing Guidelines shape the reductions as the dose gets low. Before anything changes, he goes over the risks first, then the alternatives, including staying on the medication for now, and then how the taper is expected to end. That conversation is informed consent, and the patient may decline, slow down, or hold at any point.
Professor Ashton showed that people who are dependent on a prescribed benzodiazepine do not need a deadline. They need small steps and enough time. Dr. Leeds’ practice follows that teaching for months, sometimes longer, at the pace each patient sets. Contact the office to ask about a slow, supervised taper in Florida built on the Ashton Manual.
This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.

Mark Leeds, D.O. is an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida. He helps patients come off benzodiazepines and sleeping pills with a slow, patient-directed taper guided by the Ashton Manual and the Maudsley Deprescribing Guidelines. Physical dependence is not addiction, and a careful taper is measured in months, not days.
Contact the office today to ask about a slow, medically supervised benzodiazepine taper.





